Trouble viewing this email? View in Browser

Daily HeadlinesJune 20, 2019

Concert goers stampede through the gate to get front row seating at the annual concert in 2015. (Mark Reinstein/Shutterstock Photo)

Sudden Death in Epilepsy and Breathing Troubles Linked to Bad Gene

UConn neuroscientists have found a gene mutation that causes abnormal breathing in mice with a severe form of epilepsy, mimicking the human sudden death in epilepsy syndrome. Read more.

A blood vessel blocked by red blood cells that are affected by sickle cell anemia and are crescent shaped. (Getty Images)

Sickle Cell Drug Showing Promise in Clinical Trial

In early clinical trial data, the experimental drug has shown promise for impacting important biological markers in the red and white blood cells of sickle cell patients. Read more.

Students studying at UConn Waterbury on Oct. 25, 2018. (Sean Flynn/UConn Photo)

UConn to Add Bachelor’s Program in Allied Health Sciences at Waterbury Campus

The University announced today that allied health sciences, one of the nation’s fastest-growing career fields, will soon be available at UConn Waterbury as a bachelor’s degree program that can be completed from start to finish at that campus. Read more.

Schools and Colleges

MED 12 Tips for Tick Season

CAHNR Meet alumni Joyce and David Hart

LAW A Law Professor’s Long Campaign for Justice in Bar Admissions

UConn in the News

Phys.org

Growing a Better Seaweed to Fuel the Future

ABC News

UConn Move Could be “Game Changer” for Health Care in CT and Waterbury

Tribune Publishing

Sickle Cell Treatment Drug Shows Signs of Working in Clinical Trial, UConn Researchers Say

Medicine Newsline

Investigational Drug for Treatment of Sickle Cell Disease Shows Promise in Clinical Trials

University Communications

University of Connecticut

34 North Eagleville Road, Unit 3144

Storrs, Connecticut 06269

communications.uconn.edu